ANIP 8-K 2026-11-05

ANI PHARMACEUTICALS INC (ANIP) 8-K dated 2026-11-05 — accession 0001104659-26-123446.

ANI PHARMACEUTICALS INC (ANIP) is a drug manufacturers - specialty & generic company listed on US.

ANI PHARMACEUTICALS INC filed a 8-K on 2026-11-05. Accession 0001104659-26-123446.

This 8-K covers: Material agreement (Item 1.01), New debt obligation (Item 2.03), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ANIP revenue for 2025-12-31 was $883.4M. Net income was $78.3M. Revenue was up 43.8% from 2024-12-31 to 2025-12-31. ANIP currently screens at market cap $1.41B and trailing P/E 13.8.

Not investment advice. The ANIP SEC hub lists recent forms. The stock page is the research view.